NO20060682L - Indol-6 sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorer - Google Patents
Indol-6 sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorerInfo
- Publication number
- NO20060682L NO20060682L NO20060682A NO20060682A NO20060682L NO 20060682 L NO20060682 L NO 20060682L NO 20060682 A NO20060682 A NO 20060682A NO 20060682 A NO20060682 A NO 20060682A NO 20060682 L NO20060682 L NO 20060682L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- sulfonamide derivatives
- indole
- modulators
- diastereomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Abstract
Foreliggende oppfinnelse refererer til nye sulfonamid derivater, med generell formel la.Ib.Ic), eventuelt i form av en av deres stereoisomerer, fortrinnsvis enantiomerer eller diastereomerer, deres racemate, eUer i form av en blanding av minst to av deres stereoisomerer, fortrinnsvis enantiomerer eller diastereomerer, i et hvilket som hel: blandingsforhold, eller deres salter, fortrinnsvis tUsvarende, fysiologisk akseptable salter, eller tilsvarende solvater; fremgangsmåten for deres fremstilling, deres anvendelse som medikamenter i human og/eller veterinær terapeutiske midler, og farmasøytiske sammensetninger som inneholder dem.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200301810A ES2222832B1 (es) | 2003-07-30 | 2003-07-30 | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
PCT/EP2004/008510 WO2005013976A1 (en) | 2003-07-30 | 2004-07-29 | Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060682L true NO20060682L (no) | 2006-02-10 |
Family
ID=34130544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060682A NO20060682L (no) | 2003-07-30 | 2006-02-10 | Indol-6 sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorer |
Country Status (22)
Country | Link |
---|---|
US (1) | US7462640B2 (no) |
EP (1) | EP1660077B1 (no) |
JP (1) | JP2007500164A (no) |
KR (1) | KR20060123699A (no) |
CN (1) | CN100563650C (no) |
AR (1) | AR045155A1 (no) |
AT (1) | ATE432701T1 (no) |
AU (1) | AU2004262484A1 (no) |
BR (1) | BRPI0413112A (no) |
CA (1) | CA2533970A1 (no) |
DE (1) | DE602004021394D1 (no) |
ES (2) | ES2222832B1 (no) |
IL (1) | IL172894A0 (no) |
MX (1) | MXPA06001141A (no) |
NO (1) | NO20060682L (no) |
NZ (1) | NZ545301A (no) |
PE (1) | PE20050280A1 (no) |
PT (1) | PT1660077E (no) |
RU (1) | RU2006105777A (no) |
TW (1) | TW200509907A (no) |
WO (1) | WO2005013976A1 (no) |
ZA (1) | ZA200600419B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2222832B1 (es) | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
JP2008506702A (ja) | 2004-07-14 | 2008-03-06 | ピーティーシー セラピューティクス,インコーポレーテッド | C型肝炎を治療するための方法 |
ES2246721B1 (es) * | 2004-08-10 | 2007-03-16 | Laboratorios Del Dr. Esteve, S.A. | Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos. |
EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
KR20080039982A (ko) * | 2005-08-25 | 2008-05-07 | 쉐링 코포레이션 | 작용 선택적 알파2c 아드레날린성 수용체 효능제로서의이미다졸 유도체 |
EA014470B1 (ru) * | 2006-01-24 | 2010-12-30 | Эли Лилли Энд Компани | Индолсульфонамидные модуляторы рецепторов прогестерона |
EP1953153A1 (en) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
DE102007007751A1 (de) * | 2007-02-16 | 2008-08-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007012284A1 (de) | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
EP2018861A1 (en) * | 2007-07-26 | 2009-01-28 | Laboratorios del Dr. Esteve S.A. | 5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain |
DE102007035333A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007035334A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
ATE495737T1 (de) | 2007-08-01 | 2011-02-15 | Esteve Labor Dr | Kombination von mindestens zwei 5-ht6-liganden |
DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
EP2053052A1 (en) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide |
EP2116547A1 (en) * | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands |
CN102046647A (zh) | 2008-06-06 | 2011-05-04 | 哈博生物科学公司 | 制备17-炔基-7-羟基甾族化合物和相关化合物的方法 |
ITMC20080120A1 (it) * | 2008-06-20 | 2009-12-21 | Nazario Luzi | Sistema di ripresa video in particolare per la pesca. |
EP2149573A1 (en) * | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | Substituted indole sulfonamide compounds their preparation and use as medicaments |
US20190336585A1 (en) * | 2018-05-03 | 2019-11-07 | John Lawrence Mee | Method for sustainable human cognitive enhancement |
US20190390193A1 (en) * | 2018-06-23 | 2019-12-26 | John Lawrence Mee | Reversible method for sustainable human cognitive enhancement |
RS65335B1 (sr) | 2018-10-05 | 2024-04-30 | Annapurna Bio Inc | Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću receptora apj |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472870A (en) * | 1966-08-29 | 1969-10-14 | Mead Johnson & Co | Sulfonamidotryptamines |
JPH10500960A (ja) | 1994-05-28 | 1998-01-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5ht1d−アンタゴニスト活性を有するアミド誘導体 |
MX9706969A (es) | 1995-03-20 | 1997-11-29 | Lilly Co Eli | 3-(1,2,3,6-tetrahidropiridin-4-il)-1h-indoles y 3-(piperidin-4-il)-1h-indoles sustituidos en la posicion 5: agonistas del 5-ht1f novedosos. |
DE19625184B4 (de) | 1996-06-24 | 2005-06-30 | Wabag Wassertechnik Gmbh | Verfahren zur Aufbereitung von Prozeßwasser aus einer Flaschenreinigungsmaschine |
US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
DE19753522A1 (de) * | 1997-12-03 | 1999-06-10 | Boehringer Ingelheim Pharma | Substituierte Indole, ihre Herstellung und ihre Verwendung als Arzneimittel |
GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
CA2433351A1 (en) * | 2001-01-30 | 2002-08-08 | Eli Lilly And Company | Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
CA2524682A1 (en) | 2003-05-09 | 2004-11-18 | Laboratorios Del Dr. Esteve S.A. | Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion |
JPWO2004108564A1 (ja) * | 2003-06-02 | 2006-07-20 | 株式会社マリフィット | コンテナ連結金具 |
ES2222832B1 (es) | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
-
2003
- 2003-07-30 ES ES200301810A patent/ES2222832B1/es not_active Expired - Fee Related
-
2004
- 2004-07-29 DE DE602004021394T patent/DE602004021394D1/de active Active
- 2004-07-29 MX MXPA06001141A patent/MXPA06001141A/es active IP Right Grant
- 2004-07-29 NZ NZ545301A patent/NZ545301A/en unknown
- 2004-07-29 CA CA002533970A patent/CA2533970A1/en not_active Abandoned
- 2004-07-29 BR BRPI0413112-6A patent/BRPI0413112A/pt not_active IP Right Cessation
- 2004-07-29 WO PCT/EP2004/008510 patent/WO2005013976A1/en active Application Filing
- 2004-07-29 AT AT04741319T patent/ATE432701T1/de not_active IP Right Cessation
- 2004-07-29 ZA ZA200600419A patent/ZA200600419B/en unknown
- 2004-07-29 AR ARP040102697A patent/AR045155A1/es unknown
- 2004-07-29 JP JP2006521528A patent/JP2007500164A/ja active Pending
- 2004-07-29 ES ES04741319T patent/ES2327845T3/es active Active
- 2004-07-29 RU RU2006105777/04A patent/RU2006105777A/ru unknown
- 2004-07-29 EP EP04741319A patent/EP1660077B1/en active Active
- 2004-07-29 KR KR1020067001738A patent/KR20060123699A/ko not_active Application Discontinuation
- 2004-07-29 TW TW093122667A patent/TW200509907A/zh unknown
- 2004-07-29 PT PT04741319T patent/PT1660077E/pt unknown
- 2004-07-29 US US10/566,101 patent/US7462640B2/en not_active Expired - Fee Related
- 2004-07-29 AU AU2004262484A patent/AU2004262484A1/en not_active Abandoned
- 2004-07-29 CN CNB2004800222711A patent/CN100563650C/zh not_active Expired - Fee Related
- 2004-08-02 PE PE2004000735A patent/PE20050280A1/es not_active Application Discontinuation
-
2005
- 2005-12-29 IL IL172894A patent/IL172894A0/en unknown
-
2006
- 2006-02-10 NO NO20060682A patent/NO20060682L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR045155A1 (es) | 2005-10-19 |
US7462640B2 (en) | 2008-12-09 |
RU2006105777A (ru) | 2007-09-20 |
JP2007500164A (ja) | 2007-01-11 |
PT1660077E (pt) | 2009-09-03 |
CA2533970A1 (en) | 2005-02-17 |
WO2005013976A1 (en) | 2005-02-17 |
ATE432701T1 (de) | 2009-06-15 |
DE602004021394D1 (de) | 2009-07-16 |
PE20050280A1 (es) | 2005-06-12 |
IL172894A0 (en) | 2006-06-11 |
BRPI0413112A (pt) | 2006-10-03 |
KR20060123699A (ko) | 2006-12-04 |
ES2222832A1 (es) | 2005-02-01 |
NZ545301A (en) | 2008-05-30 |
EP1660077B1 (en) | 2009-06-03 |
AU2004262484A1 (en) | 2005-02-17 |
CN1832738A (zh) | 2006-09-13 |
ES2222832B1 (es) | 2006-02-16 |
US20070043041A1 (en) | 2007-02-22 |
ZA200600419B (en) | 2007-03-28 |
ES2327845T3 (es) | 2009-11-04 |
CN100563650C (zh) | 2009-12-02 |
EP1660077A1 (en) | 2006-05-31 |
MXPA06001141A (es) | 2006-04-24 |
TW200509907A (en) | 2005-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060682L (no) | Indol-6 sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorer | |
NO20060865L (no) | Indol-5-YL sulfonamid derivater, deres fremstilling og deres anvedelse 5-HT-6 som modulatorer | |
NO20060342L (no) | 1-sulfonylindol derivater, deres fremstilling og deres andvendelse som 5-HT6 ligander | |
NO20060155L (no) | Indol-4-sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorer | |
HK1120725A1 (en) | Tetrahydro-beta-carbolin-sulfonamide derivatives as 5-ht6ligands | |
NO20055492L (no) | Anvendelse av sulfonamidderivater for fremstilling av et medikament for profylakse og/eller behandling av lidelser ved matinntak | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
DK1697370T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
UY27350A1 (es) | Azaindoles | |
NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
NO20044826L (no) | Pyrrolidinderivater | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20060908L (no) | Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse | |
AR034283A1 (es) | Compuestos heterociclilindazol y azaindazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento | |
TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
NO20091766L (no) | Spiro-piperidinderivater | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
SE0402925D0 (sv) | Novel Compounds | |
NO20050903L (no) | Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser | |
NO20060506L (no) | Indol-7-yl sulfonamid derivater, deres fremstilling og deres anvendelse i medikamenter | |
NO20080669L (no) | Acetylenpiperaziner som metabotrofiske glutamatreseptorantagonister | |
NO20092149L (no) | Spiro-piperidinderivater | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
NO20080671L (no) | Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |